{
    "paper_id": "PMC7134868",
    "metadata": {
        "title": "Treatment of SARS with human interferons",
        "authors": [
            {
                "first": "Hisashi",
                "middle": [],
                "last": "Moriguchi",
                "suffix": "",
                "email": "hisashi@ip.rcast.u-tokyo.ac.jp",
                "affiliation": {}
            },
            {
                "first": "Chifumi",
                "middle": [],
                "last": "Sato",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Sir",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "The results of J Cinatl and colleagues1 show that interferon beta is effective against SARS-CoV\u2014a membrane-enclosed RNA virus2\u2014in vitro, when used either alone or in combination with other antiviral drugs.",
            "cite_spans": [
                {
                    "start": 38,
                    "end": 39,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 125,
                    "end": 126,
                    "mention": "2",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "Their results concur with our beliefs that interferon, with its broad-spectrum antiviral activity against RNA viruses, might be useful in the treatment of SARS, either as a monotherapy or plus ribavirin.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "However, the findings of Ozes and co-workers3 show that the specific activity (antiviral units/mg) of recombinant human interferon-consensus 1 (IFN-Con1) was ten-fold higher than that of interferon alfa-2a and interferon alfa-2b in vitro. Furthermore, IFN-Con1 increases the ability of or induces natural killer cells to kill target cells to a greater extent than does interferon alfa.3\n",
            "cite_spans": [
                {
                    "start": 44,
                    "end": 45,
                    "mention": "3",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 385,
                    "end": 386,
                    "mention": "3",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "Therefore, we suggest that IFN-Con1 and IFN-Con1 plus ribavirin are assessed as potential antiviral drugs for the treatment of SARS with the method used by Cinatl and colleagues.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Treatment of SARS with human interferons",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cinatl",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Morgenstern",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Bauer",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Chandra",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Rabenau",
                    "suffix": ""
                },
                {
                    "first": "HW",
                    "middle": [],
                    "last": "Doerr",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Lancet",
            "volume": "362",
            "issn": "",
            "pages": "293-294",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Identification of a novel coronavirus in patients with severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Drosten",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gunther",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Preiser",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "N Engl J Med",
            "volume": "348",
            "issn": "",
            "pages": "1967-1976",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities",
            "authors": [
                {
                    "first": "ON",
                    "middle": [],
                    "last": "Ozes",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Reiter",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Klein",
                    "suffix": ""
                },
                {
                    "first": "LM",
                    "middle": [],
                    "last": "Blatt",
                    "suffix": ""
                },
                {
                    "first": "MW",
                    "middle": [],
                    "last": "Taylor",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "J Interferon Res",
            "volume": "12",
            "issn": "",
            "pages": "55-59",
            "other_ids": {
                "DOI": []
            }
        }
    }
}